Skip to main content
OpenTrials
Completed

NCT Number: NCT05223153

OCT-A and Amblyopia

Detect changes in retinal vessel density in the superficial and deep capillary plexuses using OCTA in children with anisometropic amblyopia

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine- Minia University

Minya, 61111, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unilateral anisometropia.
  • Refractive error less than -6.00 D and +4.00 D.
  • Age less than 12 years.
  • No previous amblyopia treatments

Exclusion criteria

  • High refractive error. 2. Bilateral amblyopia. 3. Age more than 12 years.

-

Treatment and study plan

Optical Coherence tomography angiography

Diagnostic Test

Measurement retinal vessel density in the superficial and deep capillary plexuses using OCTA in children with anisometropic amblyopia

Primary outcomes

  1. Change in retinal vessel density

    Time frame: 3 months

    Detect changes in retinal vessel density in the superficial and deep capillary plexuses using OCTA in children with anisometropic amblyopia and effect of treatment on the retinal vessel density

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Assessment of Macular Microvascular Changes Following Amblyopia Treatment in Children With Anisometropic Amblyopia Using Optical Coherence Tomography Angiography

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 3, 2022
Registry last updated
Nov 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.